Has Big Pharma Corruption Suppressed Effective Treatment Options?
July 24, 2008 Antidepressants, Antipsychotic, Big Pharma, FDA, Fraud, News, Prozac, Psychiatrist, Psychiatry, Risperdal, Seroquel, Zoloft, Zyprexa No CommentsBy Bruce E. Levine, AlterNet
Posted on July 23, 2008, Printed on July 24, 2008
American psychiatry has been rocked by Congress. Congressional investigators first exposed the financial relationships between high-profile psychiatrists and drug companies. “But now the profession itself is under attack in Congress,” reported the New York Times on July 12, 2008.
Specifically under attack is psychiatry’s premier professional organization, the American Psychiatric Association. The New York Times stated, “In 2006, the latest year for which numbers are available, the drug industry accounted for about 30 percent of the association’s $62.5 million in financing. About half of that money went to drug advertisements in psychiatric journals and exhibits at the annual meeting, and the other half to sponsor fellowships, conferences and industry symposiums at the annual meeting.”
